Intracranial tumors initiated by fibulin-3–deficient GBM cells showed increased presence of TAMs with decreased immunosuppression markers (arginase-1, CD206), whereas the opposite effects were observed in tumors overexpressing fibulin-3. The gene discussed is EFEMP1; the disease is glioblastoma.